安控科技(300370.SZ):董事長徐輝辭職
格隆匯3月20日丨安控科技(300370.SZ)公佈,公司董事會於2020年3月19日收到公司董事長徐輝提交的書面辭職報告,徐輝向董事會提出辭去公司董事長、董事等其在公司的一切職務。辭職後,徐輝將不再擔任公司任何職務。該辭職報告自送達董事會之日起生效。
經過超過半數董事推選,在選舉產生新任董事長前,由公司副董事長李春福代行履行董事長、法定代表人等職責,直至選舉產生新任董事長為止。公司將按照法定程序,儘快完成新任董事長的選舉工作。根據《公司章程》等相關規定,董事長為公司法定代表人,待董事會選舉新任董事長後,新任董事長即為法定代表人,公司將及時辦理工商變更等事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.